TAS-115
CAS No. 1190836-34-0
TAS-115 ( H2OL3Q4XRD; 4-(2-Fluoro-4-(3-(2-phenylacetyl)thioureido)phenoxy)-7-methoxy-N-methylquinoline-6-carboxamide; pamufetinib )
产品货号. M23360 CAS No. 1190836-34-0
TAS-115 is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase(IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1458 | 有现货 |
|
10MG | ¥2155 | 有现货 |
|
25MG | ¥3653 | 有现货 |
|
50MG | ¥5370 | 有现货 |
|
100MG | ¥7655 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称TAS-115
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述TAS-115 is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase(IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively).
-
产品描述TAS-115 is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase(IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively).
-
同义词H2OL3Q4XRD; 4-(2-Fluoro-4-(3-(2-phenylacetyl)thioureido)phenoxy)-7-methoxy-N-methylquinoline-6-carboxamide; pamufetinib
-
通路Angiogenesis
-
靶点VEGFR
-
受体VEGFR2;c-Met
-
研究领域——
-
适应症——
化学信息
-
CAS Number1190836-34-0
-
分子量518.6
-
分子式C27H23FN4O4S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCNC(c(cc1c(Oc(ccc(NC(NC(Cc2ccccc2)=O)=S)c2)c2F)ccnc1c1)c1OC)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Fujita H, et al. The novel VEGF receptor/MET-targeted kinase inhibitor TAS-115 has marked in vivo antitumor properties and a favorable tolerability profile. Mol Cancer Ther. 2013 Dec;12(12):2685-96.
产品手册
关联产品
-
Brivanib alaninate
A prodrug of Brivanib, which is a dual inhibitor of VEGFR2 and FGFR1 with IC50 of 25 nM and 148 nM respectively.
-
Telatinib
An orally active, small molecule inhibitor of VEGFR-2 (IC50=6 nM), VEGFR-3 (IC50=4 nM), PDEGFRα (IC50=15 nM) and c-Kit (IC50=1 nM) in biochemical assays.
-
Tivozanib
A highly potent inhibitor of pan-VEGFR with IC50s of 60/6.5/15 nM for VEGFR1/2/3.